In parallel, clinical strategies such as super-selective intra-arterial administration of radiolabeled agents, exemplified by the use of [68Ga] Ga-PSMA-11 PET/MRI, have shown a 15-fold increase in tumor uptake compared to intravenous methods, with negligible off-target effects [31]. Here, FOLH1 is linked to neoplasm.